Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial.
Jama Oncology
Goss, Glenwood D GD; Felip, Enriqueta E; Cobo, Manuel M; Lu, Shun S; Syrigos, Konstantinos K; Lee, Ki Hyeong KH; Göker, Erdem E; Georgoulias, Vassilis V; Li, Wei W; Guclu, Salih S; Isla, Dolores D; Min, Young Joo YJ; Morabito, Alessandro A; Ardizzoni, Andrea A; Gadgeel, Shirish M SM; Fülöp, Andrea A; Bühnemann, Claudia C; Gibson, Neil N; Krämer, Nicole N; Solca, Flavio F; Cseh, Agnieszka A; Ehrnrooth, Eva E; Soria, Jean-Charles JC
Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Plos One
Bodian, Dale L DL; McCutcheon, Justine N JN; Kothiyal, Prachi P; Huddleston, Kathi C KC; Iyer, Ramaswamy K RK; Vockley, Joseph G JG; Niederhuber, John E JE